Phase 2 randomized controlled trial of intravenous or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFOLFOX6 as first-line treatment of advanced gastric cancer

Zhao, S; Su, LY; Chen, YG; Li, XF; Lin, PC; Chen, WJ; Fang, WZ; Zhu, JF; Li, H; Ren, LP; Liu, J; Hong, YN; Lin, SW; Fan, NF; Lin, RB

Fan, NF; Lin, RB (通讯作者)，Fujian Med Univ, Fujian Canc Hosp, Dept Gastrointestinal Med Oncol, Clin Oncol Sch, Fuzhou, Peoples R China.;Lin, RB (通讯作者)，Fujian Key Lab Translat Canc Med, Fuzhou, Peoples R China.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

ObjectiveWe conducted a phase 2 trial to compare the safety and efficacy of intravenous paclitaxel or intraperitoneal paclitaxel plus mFOLFOX6 vs. mFO......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索